Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Latina Pharma is a leading pharmaceutical company headquartered in Lima, Peru, specializing in the marketing, distribution, and commercialization of a diverse range of healthcare products. Since its acquisition by the Mexican pharmaceutical group Sanfer in 2014, the company has significantly expanded its footprint in the Andean region, focusing on high-demand therapeutic areas such as oncology, cardiology, and gastroenterology. Latina Pharma serves as a critical strategic partner for international laboratories, providing essential regulatory, marketing, and logistics expertise to navigate the Peruvian market. The company is recognized for its robust supply chain and its commitment to improving patient access to specialized and life-saving medications. Operating as a key subsidiary of Sanfer, Latina Pharma integrates regional market knowledge with the resources of a major multinational pharmaceutical group. Its business model encompasses both the promotion of innovative therapies and the distribution of high-quality generic medicines across hospital and retail channels.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Latina Pharma.